» Articles » PMID: 31028495

A Novel Method for Analysing Frequent Observations from Questionnaires in Order to Model Patient-Reported Outcomes: Application to EXACT® Daily Diary Data from COPD Patients

Overview
Journal AAPS J
Specialty Pharmacology
Date 2019 Apr 28
PMID 31028495
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease with approximately 174 million cases worldwide. Electronic questionnaires are increasingly used for collecting patient-reported-outcome (PRO) data about disease symptoms. Our aim was to leverage PRO data, collected to record COPD disease symptoms, in a general modelling framework to enable interpretation of PRO observations in relation to disease progression and potential to predict exacerbations. The data were collected daily over a year, in a prospective, observational study. The e-questionnaire, the EXAcerbations of COPD Tool (EXACT®) included 14 items (i.e. questions) with 4 or 5 ordered categorical response options. An item response theory (IRT) model was used to relate the responses from each item to the underlying latent variable (which we refer to as disease severity), and on each item level, Markov models (MM) with 4 or 5 categories were applied to describe the dependence between consecutive observations. Minimal continuous time MMs were used and parameterised using ordinary differential equations. One hundred twenty-seven COPD patients were included (median age 67 years, 54% male, 39% current smokers), providing approximately 40,000 observations per EXACT® item. The final model suggested that, with time, patients more often reported the same scores as the previous day, i.e. the scores were more stable. The modelled COPD disease severity change over time varied markedly between subjects, but was small in the typical individual. This is the first IRT model with Markovian properties; our analysis proved them necessary for predicting symptom-defined exacerbations.

Citing Articles

A tutorial on pharmacometric Markov models.

Ooi Q, Plan E, Bergstrand M CPT Pharmacometrics Syst Pharmacol. 2024; 14(2):197-216.

PMID: 39670923 PMC: 11812945. DOI: 10.1002/psp4.13278.


A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score.

Moein A, Langenhorst J, Plan E, Jin J, Kagedal M, Kassir N Clin Transl Sci. 2023; 16(11):2310-2322.

PMID: 37718498 PMC: 10651636. DOI: 10.1111/cts.13632.


Improved Decision-Making Confidence Using Item-Based Pharmacometric Model: Illustration with a Phase II Placebo-Controlled Trial.

Llanos-Paez C, Ambery C, Yang S, Tabberer M, Beerahee M, Plan E AAPS J. 2021; 23(4):79.

PMID: 34080077 PMC: 8172506. DOI: 10.1208/s12248-021-00600-1.

References
1.
Buatois S, Retout S, Frey N, Ueckert S . Item Response Theory as an Efficient Tool to Describe a Heterogeneous Clinical Rating Scale in De Novo Idiopathic Parkinson's Disease Patients. Pharm Res. 2017; 34(10):2109-2118. DOI: 10.1007/s11095-017-2216-1. View

2.
Ramsey S, Hobbs F . Chronic obstructive pulmonary disease, risk factors, and outcome trials: comparisons with cardiovascular disease. Proc Am Thorac Soc. 2006; 3(7):635-40. DOI: 10.1513/pats.200603-094SS. View

3.
Krekels E, Novakovic A, Vermeulen A, Friberg L, Karlsson M . Item Response Theory to Quantify Longitudinal Placebo and Paliperidone Effects on PANSS Scores in Schizophrenia. CPT Pharmacometrics Syst Pharmacol. 2017; 6(8):543-551. PMC: 5572362. DOI: 10.1002/psp4.12207. View

4.
Donaldson G, Hurst J, Smith C, Hubbard R, Wedzicha J . Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2009; 137(5):1091-7. DOI: 10.1378/chest.09-2029. View

5.
Briggs A, Baker T, Risebrough N, Chambers M, Gonzalez-McQuire S, Ismaila A . Development of the Galaxy Chronic Obstructive Pulmonary Disease (COPD) Model Using Data from ECLIPSE: Internal Validation of a Linked-Equations Cohort Model. Med Decis Making. 2016; 37(4):469-480. DOI: 10.1177/0272989X16653118. View